Amazon (AMZN) shares retreat after wide Q2 earnings miss >>> READ MORE

3 Stocks to Buy in January

Biotechs and miners are starting to break out

      View All  

Stocks to Buy #1: Fibrocell Science (FCSC)

Click to Enlarge
Fibrocell Science (FCSC) is on a tear, blasting out of a downtrend pattern dating back to June on massive upside volume. Shares have already reversed the September-to-November selloff, but have another 44% to go to retest its summertime highs.

FCSC focuses on therapies for skin and connective tissue diseases and related damage, such as scarring. The technology behind this is the use of autologous fibroblast cells, which are responsible for the production of collagen — the connective protein that gives skin strength and elasticity.

Fibrocell’s LAVIV product is an interdermal injection treatment that is used as an alternative to Allergan’s (AGN) Botox to remove wrinkles, specially the smile lines on the side of the mouth. Fibrocell hopes the technology eventually will be used to provide relief to victims of severe burns.

FCSC stock is up more than 15% since I added it to my Edge Letter Sample Portfolio on Jan. 9.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC